Actualmente nos encontramos en una pandemia mundial causada por el coronavirus 2019 o COVID–19, presentando diferentes desafíos para el sistema de salud debido a que no se cuenta aún con alguna vacuna ni con un tratamiento que haya demostrado su eficacia en totalidad, siendo el manejo actual preventivo y de soporte. Por lo que, en esta revisión se estudiará a los fármacos antirreumáticos más resaltantes que tengan un probable efecto farmacológico, como son la hidroxicloroquina, el tocilizumab, el anakinra y el baricitinib, frente al COVID–19. Se espera que brinde apoyo para futuros tratamientos e investigaciones sobre la enfermedad. / We are currently in a global pandemic caused by the coronavirus 2019 or COVID- 19, presenting different challenges for the health system due to the fact that there is still no vaccine or a treatment that has proven its effectiveness in its entirety, being the management current preventive and supportive. Therefore, this review will study the most prominent antirheumatic drugs that have a probable pharmacological effect, such as hydroxychloroquine, tocilizumab, anakinra and baricitinib, against COVID-19. It is expected that they will provide support for future treatments. and research on the disease.
| Identifer | oai:union.ndltd.org:PERUUPC/oai:repositorioacademico.upc.edu.pe:10757/658028 |
| Date | 27 April 2021 |
| Creators | Salas-Bolaños, Rosa Alejandra, Sevilla-Rodriguez, David Ezequiel, Arroyo-Sánchez, Abel Salvador |
| Publisher | Association Medical Corps of the National Hospital Almanzor Aguinaga Asenjo |
| Source Sets | Universidad Peruana de Ciencias Aplicadas (UPC) |
| Language | Spanish |
| Detected Language | Spanish |
| Type | info:eu-repo/semantics/article |
| Format | application/pdf |
| Source | Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo, 14, 1, 52, 63 |
| Rights | info:eu-repo/semantics/openAccess, Attribution-NonCommercial-ShareAlike 4.0 International, http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| Relation | http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/821 |
Page generated in 0.0025 seconds